-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of the cost of borrowed funds accounted for as interest expense.
-
Summary
-
Immix Biopharma, Inc. annual/quarterly Interest Expense history and growth rate from Q1 2021 to Q2 2022.
- Immix Biopharma, Inc. Interest Expense for the quarter ending June 30, 2022 was $109.000, a 99.8% decline year-over-year.
- Immix Biopharma, Inc. Interest Expense for the twelve months ending June 30, 2022 was $98.9K.
- Immix Biopharma, Inc. annual Interest Expense for 2022 was $497.000, a 99.7% decline from 2021.
- Immix Biopharma, Inc. annual Interest Expense for 2021 was $180K, a 76.4% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)